Cargando…
Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors
Growth hormone (GH) deficiency is a common pituitary hormone deficiency in childhood cancer survivors (CCS). The identification, diagnosis, and treatment of those individuals at risk are important in order to minimize associated morbidities that can be ameliorated by treatment with recombinant human...
Autores principales: | Pollock, Netanya I., Cohen, Laurie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569790/ https://www.ncbi.nlm.nih.gov/pubmed/34745010 http://dx.doi.org/10.3389/fendo.2021.745932 |
Ejemplares similares
-
Diagnosis of childhood and adolescent growth hormone deficiency using transcriptomic data
por: Garner, Terence, et al.
Publicado: (2023) -
Macimorelin Acetate for the Diagnosis of Childhood-onset Growth Hormone Deficiency
por: Henry, Rohan K
Publicado: (2022) -
Short-term effect of growth hormone treatment in childhood leukemia survivors with growth hormone deficiency
por: Shin, Chungwoo, et al.
Publicado: (2023) -
Expert Opinion on the Management of Growth Hormone Deficiency in Brain Tumor Survivors: Results From an Italian Survey
por: Di Iorgi, Natascia, et al.
Publicado: (2022) -
Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)